Shogo Nakamoto

Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer?

Taiyo L. Harada, Takayoshi Uematsu, Kazuaki Nakashima et al. · European Radiology · 2020 · 39 citations

Medicine, Oncology, Radiology +13

A maintained absolute lymphocyte count predicts the overall survival benefit from eribulin therapy, including eribulin re-administration, in HER2-negative advanced breast cancer patients: a single-institutional experience

Junichiro Watanabe, Mitsue Saito, Yoshiya Horimoto et al. · Breast Cancer Research and Treatment · 2020 · 37 citations

Medicine, Immunology, Oncology +14

Systemic immunity markers associated with lymphocytes predict the survival benefit from paclitaxel plus bevacizumab in HER2 negative advanced breast cancer

Shogo Nakamoto, Masahiko Ikeda, Shinichiro Kubo et al. · Scientific Reports · 2021 · 28 citations · Full text

Medicine, Immunology, Oncology +17

Dynamic Changes in Absolute Lymphocyte Counts During Eribulin Therapy Are Associated With Survival Benefit

Shogo Nakamoto, Masahiko Ikeda, Shinichiro Kubo et al. · Anticancer Research · 2021 · 18 citations · Full text

Medicine, Immunology, Oncology +14

Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer

Shogo Nakamoto, Tadahiko Shien, Takayuki Iwamoto et al. · Scientific Reports · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacology +16